Germany To Ban Export Of Ozempic Weight Loss Drug
Ozempic weight loss drug packaging is seen in this illustration photo with the Novo Nordisk logo in Warsaw, Poland on 19 November, 2023. German regulator BfArM is considering banning the export of the Ozempic weight loss drug, manufactured by the Danish Novo Nordisk company due to shortages caused by popularity in the United States. Ozempic is commonly prescribed to patience with diabetes or a risk or getting diabetes however Ozempic is also effective as a stand alone weight loss solution. (Photo by Jaap Arriens/NurPhoto)
- Product Code
- ILEA002006792
- Registered date
- 2023/11/19 00:00:00
- Credit
- NurPhoto / Kyodo News Images
- Media source
- Jaap Arriens/NurPhoto
- Media size
- 4060 × 2707 pixel
- Resolution
- 240 dpi
- Deployment size
- 5.85(MB)*
- Special instruction
-
RESTRICTED TO EDITORIAL USE
*File size when opened in Photoshop, etc.
